Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Does the Alexis wound retractor increase the risk of blood splashes to the eyes? Early closure of a double blinded randomised controlled trial.

Ooi S, Stupart D, Gillies H, Watters D.

Contemp Clin Trials Commun. 2018 Jan 6;10:199-200. doi: 10.1016/j.conctc.2018.01.001. eCollection 2018 Jun. No abstract available.

2.

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Newman JH, Rich S, Abman SH, Alexander JH, Barnard J, Beck GJ, Benza RL, Bull TM, Chan SY, Chun HJ, Doogan D, Dupuis J, Erzurum SC, Frantz RP, Geraci M, Gillies H, Gladwin M, Gray MP, Hemnes AR, Herbst RS, Hernandez AF, Hill NS, Horn EM, Hunter K, Jing ZC, Johns R, Kaul S, Kawut SM, Lahm T, Leopold JA, Lewis GD, Mathai SC, McLaughlin VV, Michelakis ED, Nathan SD, Nichols W, Page G, Rabinovitch M, Rich J, Rischard F, Rounds S, Shah SJ, Tapson VF, Lowy N, Stockbridge N, Weinmann G, Xiao L.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1661-1670. doi: 10.1164/rccm.201701-0150WS.

3.

Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1).

Shapiro S, Torres F, Feldman J, Keogh A, Allard M, Blair C, Gillies H, Tislow J, Oudiz RJ.

Respir Med. 2017 May;126:84-92. doi: 10.1016/j.rmed.2017.03.025. Epub 2017 Mar 29.

PMID:
28427554
4.

Delivering high quality hip fracture rehabilitation: the perspective of occupational and physical therapy practitioners.

Leland NE, Lepore M, Wong C, Chang SH, Freeman L, Crum K, Gillies H, Nash P.

Disabil Rehabil. 2018 Mar;40(6):646-654. doi: 10.1080/09638288.2016.1273973. Epub 2017 Jan 23.

PMID:
28110561
5.

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.

Coghlan JG, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, Kuwana M, McLaughlin VV, Peacock AJ, Simonneau G, Vachiéry JL, Blair C, Gillies H, Miller KL, Harris JHN, Langley J, Rubin LJ; AMBITION investigators.

Ann Rheum Dis. 2017 Jul;76(7):1219-1227. doi: 10.1136/annrheumdis-2016-210236. Epub 2016 Dec 30.

6.

Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.

Fischer A, Denton CP, Matucci-Cerinic M, Gillies H, Blair C, Tislow J, Nathan SD.

Respir Med. 2016 Aug;117:254-63. doi: 10.1016/j.rmed.2016.06.018. Epub 2016 Jun 29.

7.

Phase I safety study of ranolazine in pulmonary arterial hypertension.

Gomberg-Maitland M, Schilz R, Mediratta A, Addetia K, Coslet S, Thomeas V, Gillies H, Oudiz RJ.

Pulm Circ. 2015 Dec;5(4):691-700. doi: 10.1086/683813.

8.

A Comparison of Discrete Event Simulation (Des) Versus Markov Models With A Practical Application to Human-Immunodeficiency Virus (Hiv).

Gillies H.

Value Health. 2015 Nov;18(7):A699. doi: 10.1016/j.jval.2015.09.2609. Epub 2015 Oct 20. No abstract available.

9.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators.

N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687.

10.

Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.

Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Wells AU, Shao L, Zhou H, Henig N, Szwarcberg J, Gillies H, Montgomery AB, O'Riordan TG.

Eur Respir J. 2015 Nov;46(5):1370-7. doi: 10.1183/13993003.01537-2014. Epub 2015 Aug 6.

11.

Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool.

Parekh WA, Ashley D, Chubb B, Gillies H, Evans M.

Diabet Med. 2015 Sep;32(9):1156-66. doi: 10.1111/dme.12771. Epub 2015 Apr 22.

12.

Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials.

Chin KM, Bartolome S, Miller K, Blair C, Gillies H, Torres F.

Int J Clin Pract. 2014 May;68(5):568-77. doi: 10.1111/ijcp.12331. Epub 2014 Feb 6.

13.

Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.

Lepist EI, Gillies H, Smith W, Hao J, Hubert C, St Claire RL 3rd, Brouwer KR, Ray AS.

PLoS One. 2014 Jan 30;9(1):e87548. doi: 10.1371/journal.pone.0087548. eCollection 2014.

14.

Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials).

Maron BA, Waxman AB, Opotowsky AR, Gillies H, Blair C, Aghamohammadzadeh R, Loscalzo J, Leopold JA.

Am J Cardiol. 2013 Sep 1;112(5):720-5. doi: 10.1016/j.amjcard.2013.04.051. Epub 2013 Jun 7.

15.

Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan.

Shapiro S, Pollock DM, Gillies H, Henig N, Allard M, Blair C, Anglen C, Kohan DE.

Am J Cardiol. 2012 Nov 1;110(9):1373-7. doi: 10.1016/j.amjcard.2012.06.040. Epub 2012 Aug 2.

16.

Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension.

Fritz JS, Blair C, Oudiz RJ, Dufton C, Olschewski H, Despain D, Gillies H, Kawut SM.

Chest. 2013 Feb 1;143(2):315-323. doi: 10.1378/chest.12-0270.

17.

Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension.

Ben-Yehuda O, Pizzuti D, Brown A, Littman M, Gillies H, Henig N, Peschel T.

J Am Coll Cardiol. 2012 Jul 3;60(1):80-1. doi: 10.1016/j.jacc.2012.03.025. Epub 2012 May 9. No abstract available.

18.

Clinical pharmacokinetics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension.

Venitz J, Zack J, Gillies H, Allard M, Regnault J, Dufton C.

J Clin Pharmacol. 2012 Dec;52(12):1784-805. doi: 10.1177/0091270011423662. Epub 2011 Dec 28. Review.

PMID:
22205719
19.

Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.

Vachiery JL, Huez S, Gillies H, Layton G, Hayashi N, Gao X, Naeije R.

Br J Clin Pharmacol. 2011 Feb;71(2):289-92. doi: 10.1111/j.1365-2125.2010.03831.x.

20.

Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction.

Jackson G, Keltai M, Csanady M, Edes I, Bellamy GR, Widimsky P, Lisa L, Gillies H.

J Sex Med. 2005 May;2(3):407-14.

PMID:
16422873
21.

Past, present, and future: a 7-year update of Viagra (sildenafil citrate).

Jackson G, Gillies H, Osterloh I.

Int J Clin Pract. 2005 Jun;59(6):680-91. Review.

PMID:
15924597
22.

Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina.

Fox KM, Thadani U, Ma PT, Nash SD, Keating Z, Czorniak MA, Gillies H, Keltai M; CAESAR I (Clinical American and European Studies of Angina and Revascularization) investigators.

Eur Heart J. 2003 Dec;24(24):2206-12.

PMID:
14659772
23.
24.

Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry tests.

Twelves CJ, Dobbs NA, Gillies HC, James CA, Rubens RD, Harper PG.

Cancer Chemother Pharmacol. 1998;42(3):229-34.

PMID:
9685058
25.

Pseudoephedrine is without ergogenic effects during prolonged exercise.

Gillies H, Derman WE, Noakes TD, Smith P, Evans A, Gabriels G.

J Appl Physiol (1985). 1996 Dec;81(6):2611-7.

26.

Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.

Dobbs NA, Twelves CJ, Gillies H, James CA, Harper PG, Rubens RD.

Cancer Chemother Pharmacol. 1995;36(6):473-6.

PMID:
7554038
27.

Drugs in sport.

Noakes TD, Gillies H.

S Afr Med J. 1994 Jun;84(6):364. No abstract available.

PMID:
7740395
28.

Extensor hallucis longus coaptation to tibialis anterior: a treatment for paralytic drop foot.

Asirvatham R, Watts HG, Gillies H.

Foot Ankle. 1993 Jul-Aug;14(6):343-6.

PMID:
8406250
29.

Attitudes of health personnel towards smoking and smoking restrictions.

Grant FM, Coleman MJ, van der Merwe WG, Gillies HC, Rubidge SP.

S Afr Med J. 1989 May 6;75(9):449-50. No abstract available.

PMID:
2718075
30.

Phase II trial of idarubicin in patients with advanced lymphoma.

Gillies H, Liang R, Rogers H, Harper P, Parapia L, Cox G, Johnson S.

Cancer Chemother Pharmacol. 1988;21(3):261-4.

PMID:
3162850
31.
32.
33.

The effects of domperidone on the absorption of levodopa in normal subjects.

Bradbrook ID, Gillies HC, Morrison PJ, Rogers HJ.

Eur J Clin Pharmacol. 1986;29(6):721-3.

PMID:
3709616
34.

Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects.

Gillies HC, Rogers HJ, Francis RJ, Galloway DB, Humphreys JE.

Eur J Clin Pharmacol. 1986;31(1):113-5.

PMID:
2877883
35.

Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects.

Bradbrook ID, Gillies HC, Morrison PJ, Robinson J, Rogers HJ, Spector RG.

Br J Clin Pharmacol. 1985 Aug;20(2):163-5.

36.

Is repeated flushing of Hickman catheters necessary?

Gillies H, Rogers HJ, Johnston J, Harper PG, Rudge CJ.

Br Med J (Clin Res Ed). 1985 Jun 8;290(6483):1708. No abstract available.

37.

International Year of Disabled Persons. How 'Hot Wheels' climbed to the top.

Gillies HI.

Aust Nurses J. 1980 Dec-1981 Jan;10(6):34-5. No abstract available.

PMID:
6450584
38.

Dextran sulphate induced arthritis in rabbits.

Steinberg J, Sledge CB, Noble J, Gillies HG.

Ann Rheum Dis. 1980 Aug;39(4):387-91.

39.
40.

Homicide in the West of Scotland.

Gillies H.

Br J Psychiatry. 1976 Feb;128:105-27.

PMID:
1252678
41.

The psychiatrist and the Scottish criminal courts.

Gillies H.

Health Bull (Edinb). 1972 Jul;30(3):214-8. No abstract available.

PMID:
5075814
42.

The management of fresh ruptures of the tendo achillis.

Gillies H, Chalmers J.

J Bone Joint Surg Am. 1970 Mar;52(2):337-43. No abstract available.

PMID:
5440011
43.

Murder in the west of Scotland.

Gillies H.

Br J Psychiatry. 1965 Nov;111(480):1087-94. No abstract available.

PMID:
5841220
44.

Cardiac arrest and acidosis.

STEWART JS, STEWART WK, GILLIES HG.

Lancet. 1962 Nov 10;2(7263):964-7. No abstract available.

PMID:
13984104
45.

Surgical replacement of the breast.

GILLIES H.

Proc R Soc Med. 1959 Aug;52:597-602. No abstract available.

46.

Plastic surgery in naval cases.

GILLIES H.

J R Nav Med Serv. 1959;45(1):7-46. No abstract available.

PMID:
13642408
47.

The Periwinkleshell principle in the treatment of the small ptotic breast.

GILLIES H, MARINO H.

Plast Reconstr Surg Transplant Bull. 1958 Jan;21(1):1-7. No abstract available.

PMID:
13517955
48.

[Methods of closing the maxillary defect with new tissue].

GILLIES H.

Acta Chir Orthop Traumatol Cech. 1957 Nov;24(6):440-2. Czech. No abstract available.

PMID:
13507917
49.

My most interesting case. XXI. The navel on the knee.

GILLIES H.

Practitioner. 1956 Oct;177(1060):512-5. No abstract available.

PMID:
13370436
50.

Acute delirious states.

GILLIES H.

Br Med J. 1956 Mar 17;1(4967):623-5. No abstract available.

Supplemental Content

Loading ...
Support Center